Elizabeth Moyal

587 total citations
10 papers, 66 citations indexed

About

Elizabeth Moyal is a scholar working on Genetics, Oncology and Surgery. According to data from OpenAlex, Elizabeth Moyal has authored 10 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Elizabeth Moyal's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Elizabeth Moyal is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Elizabeth Moyal collaborates with scholars based in France. Elizabeth Moyal's co-authors include Anne Ducassou, Anne Laprie, Claire Alapetite, Yves Pérel, Stéphanie Bolle, A. Huchet, Jacques Balosso, C. Carrié, Anne‐Isabelle Bertozzi and Pierre‐Yves Bondiau and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancers.

In The Last Decade

Elizabeth Moyal

7 papers receiving 65 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Moyal France	4	23	21	17	14	11	10	66
Prantik Das United Kingdom	4	15 0.7×	37 1.8×	16 0.9×	4 0.3×	29 2.6×	21	80
Karine Martins da Trindade Brazil	7	52 2.3×	37 1.8×	14 0.8×	14 1.0×	18 1.6×	18	117
Joëlle Lacroix France	6	13 0.6×	28 1.3×	65 3.8×	8 0.6×	5 0.5×	15	100
Khalid Hirmiz Canada	4	16 0.7×	18 0.9×	7 0.4×	6 0.4×	5 0.5×	9	57
Danny Jazmati Germany	7	15 0.7×	33 1.6×	19 1.1×	36 2.6×	18 1.6×	23	108
Alice Valoriani Italy	4	12 0.5×	12 0.6×	15 0.9×	13 0.9×	15 1.4×	6	87
Placido Bruzzaniti Italy	6	29 1.3×	13 0.6×	12 0.7×	7 0.5×	22 2.0×	15	72
Donatella Russo Italy	7	12 0.5×	34 1.6×	27 1.6×	3 0.2×	9 0.8×	14	93
Edyta Subocz Poland	7	34 1.5×	15 0.7×	18 1.1×	5 0.4×	4 0.4×	16	88
Lauren Jackson United States	3	16 0.7×	18 0.9×	12 0.7×	3 0.2×	13 1.2×	5	70

Countries citing papers authored by Elizabeth Moyal

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Moyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Moyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Moyal more than expected).

Fields of papers citing papers by Elizabeth Moyal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Moyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Moyal. The network helps show where Elizabeth Moyal may publish in the future.

Co-authorship network of co-authors of Elizabeth Moyal

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Moyal. A scholar is included among the top collaborators of Elizabeth Moyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Moyal. Elizabeth Moyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kacimi, Salah Eddine Oussama, Caroline Dehais, L. Feuvret, et al.. (2024). Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.. Journal of Clinical Oncology. 42(16_suppl). 2004–2004. 1 indexed citations

Moyal, Elizabeth, Anne Ducassou, C. Chira, et al.. (2024). High-Dose-Rate Brachytherapy for Treatment of Facial Skin Cancers: Local Control, Toxicity, and Quality of Life in 67 Patients. Cancers. 16(15). 2742–2742.

Dehais, Caroline, François Ducray, Lisa Belin, et al.. (2022). Revolumab: A phase II trial of nivolumab in recurrent IDH-mutant high-grade gliomas.. Journal of Clinical Oncology. 40(16_suppl). 2048–2048. 1 indexed citations

Modesto, A., Amélie Lusque, L. Vieillevigne, et al.. (2020). Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients. Cancer/Radiothérapie. 24(2). 88–92.

Ducassou, Anne, et al.. (2020). Radiothérapie et toxicité médullaire : actualités et perspectives. Cancer/Radiothérapie. 25(1). 55–61. 5 indexed citations

Guillamo, J.-S., François Ducray, Caroline Dehais, et al.. (2019). Characteristics and patterns of care of high-grade IDH-mutant gliomas in elderly patients: A French POLA network study. Annals of Oncology. 30. v147–v147.

Guimbaud, Rosine, L. Quéro, V. Vendrely, et al.. (2019). PRODIGE67_UCGI33 ARION: Association of radiochemotherapy and immunotherapy for the treatment of unresectable oesophageal cancer: A comparative randomized phase II trial. Annals of Oncology. 30. v322–v322. 1 indexed citations

Pouessel, Damien, A. Mervoyer, Delphine Larrieu‐Ciron, et al.. (2018). Hypofractionnated stereotactic radiotherapy and anti-PDL1 durvalumab combination in recurrent glioblastoma: Results of the phase I part of the phase I/II STERIMGLI trial.. Journal of Clinical Oncology. 36(15_suppl). 2046–2046. 7 indexed citations

Massabeau, Carole, et al.. (2017). Toxicité aiguë de la tomothérapie des cancers mammaires. Cancer/Radiothérapie. 21(3). 180–189. 11 indexed citations

10.

Laprie, Anne, Claire Alapetite, C. Carrié, et al.. (2015). Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy. Cancer/Radiothérapie. 19(8). 775–789. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact